Matches in Wikidata for { <http://www.wikidata.org/entity/Q87930195> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q87930195 description "clinical trial" @default.
- Q87930195 description "ensayu clínicu" @default.
- Q87930195 description "klinisch onderzoek" @default.
- Q87930195 description "клінічне випробування" @default.
- Q87930195 name "Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Chemotherapy as First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma" @default.
- Q87930195 name "Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Chemotherapy as First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma" @default.
- Q87930195 type Item @default.
- Q87930195 label "Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Chemotherapy as First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma" @default.
- Q87930195 label "Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Chemotherapy as First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma" @default.
- Q87930195 prefLabel "Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Chemotherapy as First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma" @default.
- Q87930195 prefLabel "Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Chemotherapy as First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma" @default.
- Q87930195 P1050 Q87930195-0F03B8D8-BEF8-41F0-A20D-40F67842EB82 @default.
- Q87930195 P1132 Q87930195-44684016-4B00-41BA-A802-CD5FCD704E9D @default.
- Q87930195 P1476 Q87930195-511918C7-0E6C-4E3F-8D2B-932969FBB657 @default.
- Q87930195 P17 Q87930195-985E6931-42D6-45A7-A72F-A847328B8B47 @default.
- Q87930195 P2899 Q87930195-1A1414DC-42D1-4814-9998-2890E45110A6 @default.
- Q87930195 P3098 Q87930195-77D18D01-D5D1-40D4-88A6-3168EF1C03E8 @default.
- Q87930195 P31 Q87930195-5301D2FA-C569-4231-9938-9C85DE325C23 @default.
- Q87930195 P4844 Q87930195-57BF5D73-2E68-43D7-95F2-B2EB9FBA2DBB @default.
- Q87930195 P4844 Q87930195-EB46D8C6-F5A3-43DA-BABD-2F02B2B025A3 @default.
- Q87930195 P4844 Q87930195-F24F9F8E-0200-4223-B6EB-41EAB839CE3D @default.
- Q87930195 P580 Q87930195-52A64E2D-13CD-4DF1-BDF3-71066527AFF4 @default.
- Q87930195 P582 Q87930195-B8F67953-6F70-45BE-9C82-B0B27CF0D09D @default.
- Q87930195 P8363 Q87930195-A0F7CD85-F789-43E4-BB52-0F4580A02274 @default.
- Q87930195 P921 Q87930195-5FCD66C4-A9C4-41D3-A961-9F8DA002478C @default.
- Q87930195 P921 Q87930195-8FFE73E3-0B7C-43D8-A22B-098FC412ED59 @default.
- Q87930195 P921 Q87930195-EE1B33A1-6886-4E7D-BDAD-1523FA3ABB11 @default.
- Q87930195 P1050 Q356033 @default.
- Q87930195 P1132 "+28" @default.
- Q87930195 P1476 "A Phase 2, Single Arm, Multi-center, Open-Label Trial to Evaluate the Safety and Efficacy of Treatment With Tumor Treating Fields (TTFields) and Chemotherapy as First-Line Treatment for Subjects With Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Gastric (GC) Adenocarcinoma" @default.
- Q87930195 P17 Q8646 @default.
- Q87930195 P2899 "+18" @default.
- Q87930195 P3098 "NCT04281576" @default.
- Q87930195 P31 Q30612 @default.
- Q87930195 P4844 Q412616 @default.
- Q87930195 P4844 Q420207 @default.
- Q87930195 P4844 Q422327 @default.
- Q87930195 P580 "2019-12-19T00:00:00Z" @default.
- Q87930195 P582 "2022-12-01T00:00:00Z" @default.
- Q87930195 P8363 Q78089383 @default.
- Q87930195 P921 Q17149644 @default.
- Q87930195 P921 Q18556047 @default.
- Q87930195 P921 Q18556563 @default.